Bayer extends collaboration


Bayer (BAYRY) signs multi-year extension with Roche's (RHHBY) Ventana Medical Systems to develop companion diagnostics focused on immunohistochemistry.

The agreement focuses on the development of diagnostic tests for Bayer's biomarker-targeted therapeutics.

Ventana will create an expert team with resources exclusively designated for Bayer.

Financial terms are undisclosed.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs